Bioinformatics-Based Approach for Exploring the Immune Cell Infiltration Patterns in Alzheimer's Disease and Determining the Intervention Mechanism of Liuwei Dihuang Pill.
PMID:35898725
Identification and Functional Analysis of Individual-Specific Subpathways in Lung Adenocarcinoma.
PMID:35885905
Development and Verification of a Combined Immune- and Metabolism-Related Prognostic Signature for Hepatocellular Carcinoma.
PMID:35874741
Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus.
PMID:35858908
An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma.
PMID:35847907
Molecular and Clinical Characterization of CD80 Expression via Large-Scale Analysis in Breast Cancer.
PMID:35814211
m6A Regulator-Mediated RNA Methylation Modification Patterns Regulate the Immune Microenvironment in Osteoarthritis.
PMID:35812736
PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas.
PMID:35800054
Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
PMID:35793235
Integrated Analysis of Immune-Related circRNA-miRNA-mRNA Regulatory Network in Ischemic Stroke.
PMID:35785353
Prognostic Characteristics of Immune-Related Genes and the Related Regulatory Axis in Patients With Stage N+M0 Breast Cancer.
PMID:35785160
Identification of an Immune-Related Prognostic Risk Model in Glioblastoma.
PMID:35783263
Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.
PMID:35756490
Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences.
PMID:35754849
Transcriptome analysis uncovers the autophagy-mediated regulatory patterns of the immune microenvironment in dilated cardiomyopathy.
PMID:35752958
Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma.
PMID:35741849
Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
PMID:35741714
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
PMID:35721151
Identification of a novel immune gene panel in tongue squamous cell carcinoma.
PMID:35702068
Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma.
PMID:35692574
Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma.
PMID:35675366
Evaluating the tumor immune profile based on a three-gene prognostic risk model in HER2 positive breast cancer.
PMID:35665772
Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma.
PMID:35620462
Identification of Immune Hub Genes Associated With Braak Stages in Alzheimer's Disease and Their Correlation of Immune Infiltration.
PMID:35619939
An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma.
PMID:35603163
Intestinal Immune Development Is Accompanied by Temporal Deviation in Microbiota Composition of Newly Hatched Pigeon Squabs.
PMID:35579441
Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer.
PMID:35578596
LANCL1 as the Key Immune Marker in Neuropathic Pain.
PMID:35510269
Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma.
PMID:35463955
Immune-related biomarkers shared by inflammatory bowel disease and liver cancer.
PMID:35452485
Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.
PMID:35429970
Construction of ceRNA networks with different types of IDH1 mutation status in low-grade glioma patients.
PMID:35402587
Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
PMID:35401707
Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma.
PMID:35399509
A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells.
PMID:35397536
Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients: a novel machine learning survival predictive system.
PMID:35395711
Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma.
PMID:35321174
Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.
PMID:35282039
Immune-Related Genes for Predicting Future Kidney Graft Loss: A Study Based on GEO Database.
PMID:35281025
An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma.
PMID:35280982
Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma.
PMID:35280360
ImmuneData: an integrated data discovery system for immunology data repositories.
PMID:35262674
Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer.
PMID:35252356
Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer.
PMID:35236887
Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses.
PMID:35197962
A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
PMID:35186111
Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma.
PMID:35155682
A novel 4 immune-related genes as diagnostic markers and correlated with immune infiltrates in major depressive disorder.
PMID:35152883
A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer.
PMID:35143037
Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data.
PMID:35140805
The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking.
PMID:35127768
Identification of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma Based on Dysregulated Immune LncRNAs.
PMID:35126519
Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia.
PMID:35111704
Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma.
PMID:35004839
Blood transcriptome analysis revealed the immune changes and immunological adaptation of wildness training giant pandas.
PMID:34985592
Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma.
PMID:34982796
Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer.
PMID:34976784
Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma.
PMID:34966643
Diagnostic Value of Immune-Related Genes in Kawasaki Disease.
PMID:34956318
Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones.
PMID:34938320
TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis.
PMID:34938284
Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment.
PMID:34900670
Analysis of the immune landscape in virus-induced cancers using a novel integrative mechanism discovery approach.
PMID:34900135
A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer.
PMID:34899849
Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis.
PMID:34899848
Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer.
PMID:34898475
Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs.
PMID:34888348
S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
PMID:34887861
Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea.
PMID:34880901
LTF Regulates the Immune Microenvironment of Prostate Cancer Through JAK/STAT3 Pathway.
PMID:34868909
Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer.
PMID:34805135
FlowKit: A Python Toolkit for Integrated Manual and Automated Cytometry Analysis Workflows.
PMID:34804056
Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma.
PMID:34796177
Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
PMID:34790797
Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses.
PMID:34765659
ImmReg: the regulon atlas of immune-related pathways across cancer types.
PMID:34755873
Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
PMID:34747719
Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
PMID:34745496
Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.
PMID:34712244
LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer.
PMID:34712062
Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis.
PMID:34708039
Empowering study of breast cancer data with application of artificial intelligence technology: promises, challenges, and use cases.
PMID:34697751
Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma.
PMID:34657509
Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
PMID:34654352
Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma.
PMID:34646307
A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma.
PMID:34627241
Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.
PMID:34621742
Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
PMID:34569303
Integrative Analysis of m6A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis.
PMID:34557492
Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.
PMID:34552614
Development and validation of a PBRM1-associated immune prognostic model for clear cell renal cell carcinoma.
PMID:34535962
Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Immunoautophagy-Related Genes and Tumor Microenvironment.
PMID:34526813
Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy.
PMID:34513318
A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma.
PMID:34414957
MAPK10 Expression as a Prognostic Marker of the Immunosuppressive Tumor Microenvironment in Human Hepatocellular Carcinoma.
PMID:34408980
An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
PMID:34398303
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study.
PMID:34376480
Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.
PMID:34354750
An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients.
PMID:34350203
Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
PMID:34342651
Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
PMID:34337046
Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
PMID:34335699
Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database.
PMID:34329197
Crosstalk between RNA-Binding Proteins and Immune Microenvironment Revealed Two RBP Regulatory Patterns with Distinct Immunophenotypes in Periodontitis.
PMID:34285922
Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples.
PMID:34267742
A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
PMID:34266411
Molecular mechanism study of HGF/c-MET pathway activation and immune regulation for a tumor diagnosis model.
PMID:34261467
Bioinformatic exploration of the immune related molecular mechanism underlying pulmonary arterial hypertension.
PMID:34252346
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
PMID:34252262
FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma.
PMID:34249967
A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma.
PMID:34249761
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma.
PMID:34221916
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
PMID:34220923
Patterns of Immune Infiltration and the Key Immune-Related Genes in Acute Type A Aortic Dissection in Bioinformatics Analyses.
PMID:34211294
SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.
PMID:34181042
Construction of lncRNA-Mediated ceRNA Network for Investigating Immune Pathogenesis of Ischemic Stroke.
PMID:34173933
An Immune-Related Signature Predicted Survival in Patients With Kidney Papillary Cell Carcinoma.
PMID:34164341
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.
PMID:34162860
Identification of a Competing Endogenous RNA Network Related to Immune Signature in Lung Adenocarcinoma.
PMID:34149807
Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma.
PMID:34135559
Development and validation of an individualized immune prognostic model in stage I-III lung squamous cell carcinoma.
PMID:34135424
Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma.
PMID:34122500
Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
PMID:34109184
Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
PMID:34047683
Immune gene prognostic signature for disease free survival of gastric cancer: Translational research of an artificial intelligence survival predictive system.
PMID:34025929
The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.
PMID:34021184
Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
PMID:34017356
The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
PMID:34016089
A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
PMID:33995646
Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
PMID:33937319
An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma.
PMID:33928021
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.
PMID:33889215
Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
PMID:33888644
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
PMID:33842318
A novel immune-related prognostic signature in epithelial ovarian carcinoma.
PMID:33819196
Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell Infiltration.
PMID:33816550
Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.
PMID:33816497
VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms.
PMID:33777032
Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
PMID:33748188
Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.
PMID:33747201
Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer.
PMID:33747044
Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
PMID:33726698
m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
PMID:33724691
TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer.
PMID:33721026
Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
PMID:33718118
Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma.
PMID:33717423
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
PMID:33671013
A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
PMID:33602220
The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
PMID:33594308
Identification of prognostic immune-related genes in rhabdoid tumor of kidney based on TARGET database analysis.
PMID:33588380
Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer.
PMID:33585188
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
PMID:33568167
Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.
PMID:33521209
A novel immunogenomic prognostic signature in lung squamous carcinoma.
PMID:33466167
Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
PMID:33465047
Aging and CMV discordance are associated with increased immune diversity between monozygotic twins.
PMID:33461563
Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.
PMID:33456631
Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
PMID:33437203
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients.
PMID:33413474
Development of nomogram based on immune-related gene FGFR4 for advanced non-small cell lung cancer patients with sensitivity to immune checkpoint inhibitors.
PMID:33407583
Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.
PMID:33392066
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
PMID:33391264
Immunological analysis and differential genes screening of venous thromboembolism.
PMID:33388092
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.
PMID:33386920
Development of a prognostic model of glioma based on immune-related genes.
PMID:33376548
Potential of Immune-Related Genes as Biomarkers for Diagnosis and Subtype Classification of Preeclampsia.
PMID:33335538
Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.
PMID:33334139
Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
PMID:33330624
Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data.
PMID:33329517
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.
PMID:33324566
Development of a prognostic signature for bladder cancer based on immune-related genes.
PMID:33313125
Nomogram Personalizes and Visualizes the Overall Survival of Patients with Triple-Negative Breast Cancer Based on the Immune Genome.
PMID:33299869
Autophagy-mediated regulation patterns contribute to the alterations of the immune microenvironment in periodontitis.
PMID:33289699
Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
PMID:33281882
A three-gene signature based on tumour microenvironment predicts overall survival of osteosarcoma in adolescents and young adults.
PMID:33281116
Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.
PMID:33269615
Integrative Metabolomics to Identify Molecular Signatures of Responses to Vaccines and Infections.
PMID:33266347
A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.
PMID:33260154
Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma.
PMID:33246289
Deciphering the combinatorial landscape of immunity.
PMID:33225996
Construction and validation of an immunity-related prognostic signature for breast cancer.
PMID:33216733
Construction of a risk signature for adrenocortical carcinoma using immune-related genes.
PMID:33209656
Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
PMID:33203792
Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
PMID:33203236
A 14 immune-related gene signature predicts clinical outcomes of kidney renal clear cell carcinoma.
PMID:33194402
Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
PMID:33193571
A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.
PMID:33193373
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
PMID:33186124
Identification of immune-related genes as prognostic factors in bladder cancer.
PMID:33184436
Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.
PMID:33154778
A novel immune-related prognostic index for predicting breast cancer overall survival.
PMID:33146847
Comprehensive analysis of prognostic immune-related genes associated with the tumor microenvironment of pancreatic ductal adenocarcinoma.
PMID:33133266
Timely access to trial data in the context of a pandemic: the time is now.
PMID:33122319
Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
PMID:33112406
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
PMID:33089373
Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
PMID:33072607
Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
PMID:33072067
Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma.
PMID:33049716
Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
PMID:33048468
Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer.
PMID:33042464
Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
PMID:33014809
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
PMID:33013820
Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma.
PMID:33005178
Prognostic value of immune scores in the microenvironment of colorectal cancer.
PMID:32994819
Prognostic value of immune related genes in lung adenocarcinoma.
PMID:32989393
Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
PMID:32983989
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
PMID:32974146
Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the tumor microenvironment of gastric cancer.
PMID:32969836
Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
PMID:32950055
Introduction to Multiparametric Flow Cytometry and Analysis of High-Dimensional Data.
PMID:32926370
Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma.
PMID:32884943
Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
PMID:32879664
Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
PMID:32873319
Integrated Genomic Characterization of the Human Immunome in Cancer.
PMID:32855206
Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
PMID:32854645
The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study.
PMID:32850416
Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
PMID:32850407
Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
PMID:32815653
Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer.
PMID:32793281
Systems immunology: Integrating multi-omics data to infer regulatory networks and hidden drivers of immunity.
PMID:32789283
Network Approaches for Dissecting the Immune System.
PMID:32717640
Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis.
PMID:32699529
Development of an immune-related prognostic model for pediatric acute lymphoblastic leukemia patients.
PMID:32666718
Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
PMID:32624696
A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
PMID:32588760
Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer.
PMID:32569190
A novel prognostic signature of immune-related genes for patients with colorectal cancer.
PMID:32564470
Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies.
PMID:32537435
Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.
PMID:32411773
Expression Profiling and Cell Type Classification Analysis in Periodontitis Reveal Dysregulation of Multiple lncRNAs in Plasma Cells.
PMID:32411181
Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis.
PMID:32355728
Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer.
PMID:32352015
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
PMID:32351547
Meta-Analysis of Vaginal Microbiome Data Provides New Insights Into Preterm Birth.
PMID:32322240
Identification of an immune-related signature for the prognosis of uveal melanoma.
PMID:32309184
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort.
PMID:32296685
Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms.
PMID:32296631
Transcriptome signatures from discordant sibling pairs reveal changes in peripheral blood immune cell composition in Autism Spectrum Disorder.
PMID:32291385
Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
PMID:32286381
The CEDAR Workbench: An Ontology-Assisted Environment for Authoring Metadata that Describe Scientific Experiments.
PMID:32219223
Development of an immune-related prognostic index associated with hepatocellular carcinoma.
PMID:32191631
Molecular classification of breast cancer using the mRNA expression profiles of immune-related genes.
PMID:32179831
Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma.
PMID:32158466
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.
PMID:32143735
Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
PMID:32117435
Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus.
PMID:32094927
Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers.
PMID:32081859
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
PMID:32046766
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
PMID:32039832
Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma.
PMID:32028264
IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis.
PMID:32019546
Open Data Revolution in Clinical Research: Opportunities and Challenges.
PMID:32004409
Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types.
PMID:32002550
Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set.
PMID:31929113
Immune monitoring using mass cytometry and related high-dimensional imaging approaches.
PMID:31892734
VIO: ontology classification and study of vaccine responses given various experimental and analytical conditions.
PMID:31865910
A systematic analysis of immune genes and overall survival in cancer patients.
PMID:31842801
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma.
PMID:31824866
Prognostic value of immune-related genes in clear cell renal cell carcinoma.
PMID:31821170
Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.
PMID:31741756
An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma.
PMID:31695415
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).
PMID:31633216
Moving from Empirical to Rational Vaccine Design in the 'Omics' Era.
PMID:31416125
IRNdb: the database of immunologically relevant non-coding RNAs.
PMID:31414702
Laboratory mice born to wild mice have natural microbiota and model human immune responses.
PMID:31371577
An immune-related gene signature predicts prognosis of gastric cancer.
PMID:31277152
Development and validation of an immune-related gene pairs signature in colorectal cancer.
PMID:31143520
Novel immune-risk score of gastric cancer: A molecular prediction model combining the value of immune-risk status and chemosensitivity.
PMID:30945466
A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm.
PMID:30852461
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
PMID:30832680
Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
PMID:30661062
A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers.
PMID:30622534
Development and validation of an immune gene-set based Prognostic signature in ovarian cancer.
PMID:30594555
Construction of immune-related risk signature for renal papillary cell carcinoma.
PMID:30516029
Enabling precision medicine in neonatology, an integrated repository for preterm birth research.
PMID:30398470
The Immune Epitope Database (IEDB): 2018 update.
PMID:30357391
The 10,000 Immunomes Project: Building a Resource for Human Immunology.
PMID:30304689
Robust prediction of clinical outcomes using cytometry data.
PMID:30169745
Genome wide transcriptome analysis provides bases on colonic mucosal immune system development affected by colostrum feeding strategies in neonatal calves.
PMID:30153793
MetaCyto: A Tool for Automated Meta-analysis of Mass and Flow Cytometry Data.
PMID:30067990
Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
PMID:29921729
Immune-centric network of cytokines and cells in disease context identified by computational mining of PubMed.
PMID:29912209
Unique features and clinical importance of acute alloreactive immune responses.
PMID:29769441
FAIR principles and the IEDB: short-term improvements and a long-term vision of OBO-foundry mediated machine-actionable interoperability.
PMID:29688354
Rebooting Human Immunology.
PMID:29490162
ImmPort, toward repurposing of open access immunological assay data for translational and clinical research.
PMID:29485622
DataMed - an open source discovery index for finding biomedical datasets.
PMID:29346583
LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations.
PMID:29325141
Cell type discovery and representation in the era of high-content single cell phenotyping.
PMID:29322913
Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.
PMID:29259604
Data discovery with DATS: exemplar adoptions and lessons learned.
PMID:29228196
Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data.
PMID:29163494
Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data.
PMID:29144493
xCell: digitally portraying the tissue cellular heterogeneity landscape.
PMID:29141660
Guidelines for the use of flow cytometry and cell sorting in immunological studies.
PMID:29023707
Big data management challenges in health research-a literature review.
PMID:28968677
Transcriptomic Signatures of Tacaribe Virus-Infected Jamaican Fruit Bats.
PMID:28959737
Precision annotation of digital samples in NCBI's gene expression omnibus.
PMID:28925997
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
PMID:28687838
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
PMID:28652380
Predicting structured metadata from unstructured metadata.
PMID:28637268
Investigating the neuroimmunogenic architecture of schizophrenia.
PMID:28485405
Drug repurposing from the perspective of pharmaceutical companies.
PMID:28369768
Better living through ontologies at the Immune Epitope Database.
PMID:28365732
The Repertoire Dissimilarity Index as a method to compare lymphocyte receptor repertoires.
PMID:28264647
Big and disparate data: considerations for pediatric consortia.
PMID:28134706
RImmPort: an R/Bioconductor package that enables ready-for-analysis immunology research data.
PMID:28057685
Solving Immunology?
PMID:27986392
Human immune system variation.
PMID:27916977
Protein Ontology (PRO): enhancing and scaling up the representation of protein entities.
PMID:27899649
Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers.
PMID:27863400
Systematic Analysis of Cell-to-Cell Expression Variation of T Lymphocytes in a Human Cohort Identifies Aging and Genetic Associations.
PMID:27851916
RNA-Seq Transcriptomic Responses of Full-Thickness Dermal Excision Wounds to Pseudomonas aeruginosa Acute and Biofilm Infection.
PMID:27792773
VDJML: a file format with tools for capturing the results of inferring immune receptor rearrangements.
PMID:27766961
The Ontology of Biological and Clinical Statistics (OBCS) for standardized and reproducible statistical analysis.
PMID:27627881
Transcriptome analysis reveals regional and temporal differences in mucosal immune system development in the small intestine of neonatal calves.
PMID:27515123
The Cell Ontology 2016: enhanced content, modularization, and ontology interoperability.
PMID:27377652
Computational genomics tools for dissecting tumour-immune cell interactions.
PMID:27376489
Seasonal immunoregulation in a naturally-occurring vertebrate.
PMID:27189372
G-DOC Plus - an integrative bioinformatics platform for precision medicine.
PMID:27130330
An interaction quantitative trait loci tool implicates epistatic functional variants in an apoptosis pathway in smallpox vaccine eQTL data.
PMID:27052692
DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.
PMID:26776196
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.
PMID:26682988
Immune modulators in disease: integrating knowledge from the biomedical literature and gene expression.
PMID:26661719
Antiviral innate immunity through the lens of systems biology.
PMID:26657882
Opening clinical trial data: are the voluntary data-sharing portals enough?
PMID:26560699
Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment.
PMID:26387933
Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases.
PMID:26362267
An Introduction to Automated Flow Cytometry Gating Tools and Their Implementation.
PMID:26284066
The center for expanded data annotation and retrieval.
PMID:26112029
The Regulatory T Cell Lineage Factor Foxp3 Regulates Gene Expression through Several Distinct Mechanisms Mostly Independent of Direct DNA Binding.
PMID:26107960
Vaccinology in the era of high-throughput biology.
PMID:25964458
Systems vaccinology: Enabling rational vaccine design with systems biological approaches.
PMID:25858860
Microbes on the edge of Occam's razor.
PMID:25433677
Whole genome sequencing of SIV-infected macaques identifies candidate loci that may contribute to host control of virus replication.
PMID:25418588